Haplotype of smoothelin gene associated with essential hypertension

Hereditas

Volumn 149, Issue 5, 2012, Pages 178-185

  Jiang, Jie ^a,b   Nakayama, Tomohiro ^a   Shimodaira, Masanori ^a   Sato, Naoyuki ^a   Aoi, Noriko ^a   Sato, Mikano ^a   Izumi, Yoichi ^a   Kasamaki, Yuji ^a   Ohta, Masakatsu ^a   Soma, Masayoshi ^a   Matsumoto, Koichi ^a   Kawamura, Hiroshi ^a   Ozawa, Yukio ^a   Ma, Yitong ^b  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; GUANINE; SMOOTHELIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; ESSENTIAL HYPERTENSION; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; HAPLOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CYTOSKELETAL PROTEINS; EXONS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HYPERTENSION; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MUSCLE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

ANIMALIA; MUS;

EID: 84868300932     PISSN: 00180661     EISSN: 16015223     Source Type: Journal    
DOI: 10.1111/j.1601-5223.2012.02242.x     Document Type: Article

References (28)

1. Aoi N., Nakayama T., Soma M. et al. 2010. Association of the Insulin-like growth factor-1 gene with myocardial infarction in Japanese subjects. Hereditas 147: 215-224.
2. Bar H., Wende P., Watson L. et al. 2002. Smoothelin is an indicator of reversible phenotype modulation of smooth muscle cells in balloon-injured rat carotid arteries. Basic Res. Cardiol. 97: 9-16.
3. Chao J., Yang Z., Jin L. et al. 1997. Kallikrein gene therapy in newborn and adult hypertensive rats. 1997.- Can. J. Physiol. Pharmacol. 75: 750-756.
4. Dempster A., Laird N. and Rubin D. 1977. Maximum likelihood from in complete data via the EM algorithm. J. R. Stat. Soc. 39: 1-22.
5. Guidelines Subcommittee 1999. World Health Organization Int. Soc. of Hypertension Guidelines for the Management of Hypertension. J. Hypertens. 17: 151-183.
6. Hao H., Gabbiani G., Camenzind E. et al. 2006. Phenotypic modulation of intima and media smooth muscle cells in fatal cases of coronary artery lesion. Arterioscler. Thromb. Vasc. Biol. 26: 326-332.
7. Jochen K., Christina Q., Joerg M. et al. 2001. Identification and characterization of novel smoothelin isoforms in vascular smooth muscle. J. Vasc. Res. 38: 120-132.
8. Korenbaum E. and Rivero F. 2002. Calponin homology domains at a glance. J. Cell Sci. 115: 3543-3545.
9. Livak K., Marmaro J. and Todd J. 1995. Towards fully automated genome-wide polymorphism screening. Nat. Genet. 9: 341-342.
10. Maeng M., Mertz H., Nielsen S. et al. 2003. Adventitial myofibroblasts play no major role in neointima formation after angioplasty. Scand. Cardiovasc. J. 37: 34-42.
11. Morris R. W. and Kaplan N. L. 2002. On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet. Epidemiol. 23: 221-233.
12. Naganuma T., Nakayama T., Sato N. et al. 2008. Association of extracellular superoxide dismutase gene with cerebral infarction in women: a haplotype-based case-control study. Hereditas 145: 283-292.
13. Nakayama T., Soma M., Rahmutula D. et al. 2001. Isolation of the 5′-flanking region of genes by thermal asymmetric interlaced polymerase chain reaction. Med. Sci. Monit. 7: 345-349.
14. Niessen P., Clément S., Fontao L. et al. 2004. Biochemical evidence for interaction between smoothelin and filamentous actin. Exp. Cell Res. 292: 170-178.
15. Niessen P., Rensen S., van Deursen J. et al. 2005. Smoothelin-a is essential for functional intestinal smooth muscle con tractility in mice. Gastroenterology 129: 1592-1601.
16. Olson J. and Wijsman E. 1994. Design and sample-size considerations in the detection of linkage disequilibrium with a disease locus. Am. J. Hum. Genet. 55: 574-580.
17. Ramirez-Lorca R., Grilo A., Martinez-Larrad M. T. et al. 2007. Sex and body mass index specific regulation of blood pressure by CYP19A1 gene variants. Hypertension 50: 884-890.
18. Rensen S., Thijssen V., De Vries C. et al. 2002. Expression of the smoothelin gene is mediated by alternative promoters. Cardiovasc. Res. 55: 850-863.
19. Rensen S., Niessen P., van Deursen J. et al. 2008. Smoothelin-B deficiency results in reduced arterial contractility, hyper tension, and cardiac hypertrophy in mice. Circulation 118: 828-836.
20. Stephens J., Schneider J., Tanguay D. et al. 2001. Haplotype variation and linkage disequilibrium in 313 human genes. Science 293: 489-493.
21. van der Heijden O. W., Essers Y. P., Simkens L. H. et al. 2004. Aging blunts remodeling of the uterine artery during murine pregnancy. J. Soc. Gynecol. Investig. 11: 304-310.
22. van der Loop F. T., Gabbiani G., Kohnen G. et al. 1997. Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype. Arterioscler. Thromb. Vasc. Biol. 17: 665-671.
23. van Eys G. J., Völler M. C., Timmer E. D. et al. 1997. Smoothelin expression characteristics: development of a smooth muscle cell in vitro system and identification of a vascular variant. Cell Struct. Funct. 22: 65-72.
24. van Eys G. J., Niessen P. M. and Rensen S. S. 2007. Smoothelin in vascular smooth muscle cells. Trends Cardiovasc. Med. 17: 26-30.
25. Wehrens X., Mies G., Gimona M. et al. 1997. Substructural localization of smoothelin and a vascular specific variant. FEBS Lett. 405: 315-320.
26. Yamaguchi M., Nakayama T., Fu Z. et al. 2010. The haplotype of the CACNA1B gene associated with cerebral infarction in Japanese. Hereditas 147: 313-319.
27. Zhang K., Calabrese P., Nordborg M. et al. 2002. Haplotype block structure and its applications to association studies: power and study designs. Am. J. Hum. Genet. 71: 1384-1391.
28. Zhao Y., Xia S. and Zou L. 2007. The association between polymorphism of TNF-α gene and hypertensive disorder complicating pregnancy. J. Huazhong Univ. Sci. Technol. 27: 729-732.